CPIX vs PATH
Cumberland Pharmaceuticals Inc (CPIX) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Cumberland Pharmaceuticals Inc (CPIX) is a drug manufacturers - specialty & generic company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported CPIX revenue for 2024-12-31 was $10.4M. Net income was -$1.9M. Revenue was up 14.9% from 2024-09-30 to 2024-12-31. CPIX currently screens at market cap $86.9M.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
CPIX currently screens at market cap $86.9M. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the CPIX and PATH stock pages for the full models.
Not investment advice.